Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Genetic Services Laboratory University of Chicago United States | 116 | 137 |
|
Genetic Services Laboratory University of Chicago United States | 117 | 137 |
|
SYNE1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 971 | 680 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 480 | 254 |
|
Comprehensive Neuromuscular Panel PreventionGenetics, part of Exact Sciences United States | 185 | 142 |
|
Spinocerebellar Ataxia, Autosomal Recessive-8 via the SYNE1 Gene Exons 2-146 PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 3 | 1 |
|
Congenital muscular dystrophy and LGMD panel. 42-gene NGS panel. Genologica Medica Spain | 96 | 42 |
|
Hereditary ataxias. NGS panel of 139 genes. Genologica Medica Spain | 220 | 139 |
|
Ataxia panel. NGS panel of 157 genes. Genologica Medica Spain | 247 | 156 |
|
Girdle muscular dystrophy. NGS panel of 39 genes. Genologica Medica Spain | 84 | 39 |
|
Skeletal diseases. NGS panel of 169 genes. Genologica Medica Spain | 373 | 169 |
|
Neuromuscular Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 138 | 62 |
|
Fulgent Genetics United States | 186 | 61 |
|
Fulgent Genetics United States | 133 | 56 |
|
Autosomal Recessive Cerebellar Ataxia Type 1 (SYNE1 Single Gene Test) Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 535 | 152 |
|
Emery-Dreifuss Muscular Dystrophy: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 8 | 6 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.